This work is licensed under the Creative Commons Attribution 4.0 International License.
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–9.Search in Google Scholar
Segura-Azuara N de los Á, Varela-Chinchilla CD, Trinidad-Calderón PA. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Front Med (Lausanne) .2022; 8. Available from: https://pubmed.ncbi.nlm.nih.gov/35096868/.Search in Google Scholar
Carnagarin R, Tan K, Adams L, et al. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. Int J Mol Sci. 2021; 22(8). Available from: https://pubmed.ncbi.nlm.nih.gov/33921881/.Search in Google Scholar
Datz C, Müller E, Aigner E. Iron overload and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42(2):173–83.Search in Google Scholar
Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? Liver Int. 2022;42(7):1496–502.Search in Google Scholar
Deugnier Y, Bardou-Jacquet É, Lainé F. Dysmetabolic iron overload syndrome (DIOS). Presse Med. 2017;46(12 Pt 2):e306–11.Search in Google Scholar
Kowdley K V., Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(1):77–85.Search in Google Scholar
Ryan JD, Armitage AE, Cobbold JF, et al. Hepatic iron is the major determinant of serum ferritin in NAFLD patients. Liver Int. 2018;38(1):164–73.Search in Google Scholar
Yan JX, Pan BJ, Zhao PP, Wang LT, Liu JF, Fu SB. Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes. Endocr Connect. 2021;10(12):1560.Search in Google Scholar
Shah RA, Kowdley K V. Serum ferritin as a biomarker for NAFLD: ready for prime time? Hepatol Int. 2019;13(2):110–2.Search in Google Scholar
Moris W, Verhaegh P, Jonkers D, Deursen C Van, Koek G. Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? Semin Liver Dis. 2019;39(4):476–82.Search in Google Scholar
Ellervik C, Mandrup-Poulsen T, Andersen HU, et al. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care. 2011;34(10):2256–8.Search in Google Scholar
Yang HH, Chen GC, Li DM, et al. Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Sci Rep. 2021; 11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34002001/.Search in Google Scholar
